Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ESTA NYSE:INSP NASDAQ:IRTC NASDAQ:SLNO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$41.34-1.5%$40.41$26.56▼$50.85$1.21B0.83303,225 shs316,182 shsINSPInspire Medical Systems$126.15+1.3%$131.78$123.25▼$225.00$3.67B1.22558,548 shs907,460 shsIRTCiRhythm Technologies$164.97+17.7%$142.68$55.92▼$168.32$4.48B1.41416,173 shs1.88 million shsSLNOSoleno Therapeutics$86.00-0.5%$82.06$41.50▼$90.32$4.36B-2.561.41 million shs1.04 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs-1.48%-2.52%-6.81%+23.81%-6.98%INSPInspire Medical Systems+1.29%-2.24%-3.42%-21.10%-10.56%IRTCiRhythm Technologies+17.68%+22.95%+15.54%+25.82%+91.27%SLNOSoleno Therapeutics-0.54%-0.54%-0.24%+14.32%+78.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationESTAEstablishment Labs1.7276 of 5 stars3.40.00.00.01.42.50.6INSPInspire Medical Systems4.7246 of 5 stars4.41.00.04.83.02.51.9IRTCiRhythm Technologies1.803 of 5 stars2.53.00.00.03.30.80.6SLNOSoleno Therapeutics4.2857 of 5 stars3.51.00.04.64.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESTAEstablishment Labs 2.83Moderate Buy$54.8332.64% UpsideINSPInspire Medical Systems 2.73Moderate Buy$208.5565.32% UpsideIRTCiRhythm Technologies 2.90Moderate Buy$157.30-4.65% DownsideSLNOSoleno Therapeutics 3.09Buy$108.7026.40% UpsideCurrent Analyst Ratings BreakdownLatest ESTA, SLNO, IRTC, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025IRTCiRhythm TechnologiesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$145.00 ➝ $190.008/1/2025IRTCiRhythm TechnologiesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$139.00 ➝ $170.008/1/2025IRTCiRhythm TechnologiesWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $180.008/1/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$151.00 ➝ $180.007/22/2025INSPInspire Medical SystemsKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$216.00 ➝ $197.007/16/2025ESTAEstablishment LabsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$58.00 ➝ $70.007/15/2025INSPInspire Medical SystemsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$200.00 ➝ $182.007/15/2025IRTCiRhythm TechnologiesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$160.00 ➝ $147.007/11/2025SLNOSoleno TherapeuticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperform ➝ Outperform$105.00 ➝ $121.007/9/2025ESTAEstablishment LabsCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $47.006/23/2025SLNOSoleno TherapeuticsCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESTAEstablishment Labs$166.02M7.20N/AN/A$1.90 per share21.76INSPInspire Medical Systems$802.80M4.63$1.73 per share72.89$23.01 per share5.48IRTCiRhythm Technologies$591.84M8.90N/AN/A$2.90 per share56.89SLNOSoleno TherapeuticsN/AN/AN/AN/A$5.68 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESTAEstablishment Labs-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/7/2025 (Estimated)INSPInspire Medical Systems$53.51M$2.1758.1339.181.917.92%10.00%8.68%8/5/2025 (Estimated)IRTCiRhythm Technologies-$113.29M-$3.14N/AN/AN/A-14.06%-95.60%-8.61%N/ASLNOSoleno Therapeutics-$175.85M-$4.62N/AN/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)Latest ESTA, SLNO, IRTC, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025ESTAEstablishment Labs-$0.54N/AN/AN/A$50.80 millionN/A8/6/2025Q2 2025SLNOSoleno Therapeutics-$0.85N/AN/AN/A$3.91 millionN/A8/5/2025Q2 2025INSPInspire Medical Systems$0.22N/AN/AN/A$214.50 millionN/A7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million5/7/2025Q1 2025ESTAEstablishment Labs-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million5/7/2025Q1 2025SLNOSoleno Therapeutics-$1.14-$0.95+$0.19-$0.95N/AN/A5/5/2025Q1 2025INSPInspire Medical Systems-$0.23$0.10+$0.33$0.10$194.89 million$201.32 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthESTAEstablishment LabsN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESTAEstablishment Labs5.723.362.05INSPInspire Medical SystemsN/A9.017.44IRTCiRhythm Technologies7.475.715.58SLNOSoleno Therapeutics0.2119.6419.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESTAEstablishment Labs72.91%INSPInspire Medical Systems94.91%IRTCiRhythm TechnologiesN/ASLNOSoleno Therapeutics97.42%Insider OwnershipCompanyInsider OwnershipESTAEstablishment Labs11.09%INSPInspire Medical Systems4.10%IRTCiRhythm Technologies1.10%SLNOSoleno Therapeutics6.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESTAEstablishment Labs1,01828.92 million25.71 millionOptionableINSPInspire Medical Systems1,24629.49 million28.29 millionOptionableIRTCiRhythm Technologies2,00031.92 million31.57 millionOptionableSLNOSoleno Therapeutics3050.39 million47.17 millionOptionableESTA, SLNO, IRTC, and INSP HeadlinesRecent News About These CompaniesSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by TD Asset Management IncAugust 2 at 3:18 AM | marketbeat.comXTX Topco Ltd Boosts Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 1 at 3:28 AM | marketbeat.comSoleno Therapeutics (SLNO) to Release Quarterly Earnings on WednesdayJuly 30 at 5:46 AM | marketbeat.comRoyce & Associates LP Invests $286,000 in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 30 at 3:07 AM | marketbeat.com36,495 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Acquired by Universal Beteiligungs und Servicegesellschaft mbHJuly 30 at 3:07 AM | marketbeat.comSkandinaviska Enskilda Banken AB publ Purchases 15,101 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 29, 2025 | marketbeat.comRWC Asset Management LLP Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 28, 2025 | marketbeat.comBryce Point Capital LLC Decreases Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 28, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI) and Soleno Therapeutics (SLNO)July 27, 2025 | theglobeandmail.comLegato Capital Management LLC Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 26, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Raised to "Hold" at Wall Street ZenJuly 26, 2025 | marketbeat.comSoleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy?July 25, 2025 | zacks.comHere's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price StrengthJuly 23, 2025 | msn.comCan Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect?July 23, 2025 | zacks.com40,425 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Purchased by Y Intercept Hong Kong LtdJuly 23, 2025 | marketbeat.comReadystate Asset Management LP Buys 49,422 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 22, 2025 | marketbeat.comSoleno Therapeutics’ Vykat XR Exceeds Sales ExpectationsJuly 21, 2025 | msn.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Atle Fund Management ABJuly 19, 2025 | marketbeat.com11 Best Performing Mid Cap Stocks So Far In 2025July 18, 2025 | insidermonkey.comFY2025 EPS Estimates for SLNO Raised by Cantor FitzgeraldJuly 18, 2025 | marketbeat.comBank of New York Mellon Corp Buys 234,649 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 18, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesChipotle: Too Spicy for Smart Money to Resist After Stock SplitBy Jeffrey Neal Johnson | July 11, 2025View Chipotle: Too Spicy for Smart Money to Resist After Stock SplitIs China Investable Again? 2 Stocks Soaring as Tensions EaseBy Dan Schmidt | July 21, 2025View Is China Investable Again? 2 Stocks Soaring as Tensions EaseWhy Prologis May Be the Smartest Backdoor Bet on AI Real EstateBy Chris Markoch | July 17, 2025View Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate3 Fast Food Stocks That Won’t Give You Indigestion Right NowBy Brian O'Connell | July 16, 2025View 3 Fast Food Stocks That Won’t Give You Indigestion Right NowHow Texas Roadhouse Is Winning in a Changing Consumer MarketBy Dan Schmidt | July 14, 2025View How Texas Roadhouse Is Winning in a Changing Consumer MarketESTA, SLNO, IRTC, and INSP Company DescriptionsEstablishment Labs NASDAQ:ESTA$41.34 -0.62 (-1.48%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$41.01 -0.33 (-0.80%) As of 08/1/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Inspire Medical Systems NYSE:INSP$126.15 +1.61 (+1.29%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$127.50 +1.35 (+1.07%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.iRhythm Technologies NASDAQ:IRTC$164.97 +24.79 (+17.68%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$169.57 +4.60 (+2.79%) As of 08/1/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Soleno Therapeutics NASDAQ:SLNO$86.00 -0.47 (-0.54%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$87.00 +1.00 (+1.16%) As of 08/1/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
